Company
Every investor coverage indicates participated in a round National Breast Cancer Foundation raised.
Companies National Breast Cancer Foundation acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Prof Sherene Loi | Endowed Chair | Brandon Capital portfolio |
Stories naming National Breast Cancer Foundation. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Cancer biotech Amaroq Therapeutics appointed four experts to its advisory board as it moves toward clinical trials; the New Zealand company's backers include Brandon Capital, which reports $14m invested to date.